Drug resistance in Plasmodium falciparum malaria

Infection

Volumn 27, Issue SUPPL. 2, 1999, Pages

  Warhurst, D C ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; FOLIC ACID ANTAGONIST; HEMIN; MEMBRANE PROTEIN; TETRAHYDROFOLIC ACID;

CONFERENCE PAPER; DRUG TRANSPORT; ELECTRON TRANSPORT; ENZYME STRUCTURE; HUMAN; MALARIA FALCIPARUM; OXIDATION REDUCTION REACTION; PLASMODIUM FALCIPARUM; SCHIZONT;

ANIMALS; ANTIMALARIALS; DRUG RESISTANCE, MICROBIAL; HUMANS; MALARIA, FALCIPARUM; PLASMODIUM FALCIPARUM; SENSITIVITY AND SPECIFICITY;

EID: 0032822086     PISSN: 03008126     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02561674     Document Type: Conference Paper

References (22)

1. Chou, A. C., Chevli, R., Fitch, C. D.: Ferriprotoporphyrin IX fulfils the criteria for identification as the chloroquine receptor of malaria parasites. Biochemistry 19 (1980) 1543-1549.
2. Bohle, D. S., Dinnebier, R. E., Madsen, S. K., Stephens, P. W.: Characterization of the products of the heme detoxification pathway in malarial late trophozoites by X-ray diffraction. J. Biol. Chem. 272 (1997) 713-716.
3. Bray, P., Mungthin, M., Ridley, R. G., Ward, S. A.: Access to haematin: the basis of chloroquine-resistance. Mol. Pharmacol. 54 (1998) 170-179.
4. Meshnick, S. R., Taylor,T. E., Kamchongwongpaisan, S.: Artemisinin and the antimalarial endoperoxides: from herbal remedy to targeted chemotherapy, Microbiol. Rev. 60 (1996) 301-315.
5. Peters, W.; Chemotherapy and drug resistance in malaria. Academic Press, London 1987.
6. Trape, J. F., Pison, G., Preziosi, M. P., Enel, C., Desgrees du Lou, A., Delaumay, V., Samb, B., Lagarde, E., Molez, J. F., Simondon, F.: Impact of chloroquine-resistance on malaria mortality. C. R. Acad. Sci. III. 321 (1998) 689-697.
7. Adagu, I. S., Dias, F., Pinheiro, L., Rumbo, L., Rosario, V. D., Warhursf, D. C: Guinea Bissau: association of chloroquine resistance of Plasmodium falciparum with the Tyr86 allele of the multiple drug-resistance gene Pfmdrl. Trans. R. Soc. Trop. Med. Hyg. 90 (1996) 90-91.
8. Wellems, T. E., Wootton, J. C., Fujioka, H., Su, X., Cooper, R., Baruch, D., Fidock, D. A.: P. falciparum CG2, linked to chloroquine resistance, does not resemble Na+/H+ exchangers. Cell 94 (1998) 285-286.
9. Wilson, C. M., Volkman, S. K., Thaithong, S., Martin, R. K., Kyle, D. E., Milhouse, W. K., Wirth, D. F.: Amplification of Pfmdrl associated with mefloquine and halofantrine resistance in Plasmodium falciparum from Thailand. Mol. Biochem. Parasitol. 57 (1993) 151-160.
10. Burchard, G. D., Horstmann, R. D., Wernsdorfer, W. H., Dietrich, M.: Plasmodium falciparum malaria: resistance to chloroquine, but sensitivity to mefloquine in the Gabon. A prospective in-vitro study. Trop. Med. Parasitol. 35 (1984) 1-4.
11. von Seidlein, L., Bojang, K., Jones, P., Jaffar, S., Pinder, M., Obaro, S., Doherty, T., Haywood, M., Snounou, G., Gemperli, B., Gathmann, I., Royce, C., McAdam, K., Greenwood, B.: A randomized controlled trial of artemether/benflumetol, a new antimalarial and pyrimethamine/sulfadoxine in the treatment of uncomplicated falciparum malaria in African children. Am. J. Trop. Med. Hyg. 58 (1998) 638-644.
12. White, N. J.: Preventing antimalarial drug resistance through combinations. Drug Resist. Updates 1 (1998) 3-9.
13. Chawira, A. N., Warhurst, D. C., Robinson, B. L., Peters, W.: The effect of combinations of qinghaosu (artemisinin) with standard antimalarial drugs in the suppressive treatment of malaria in mice. Trans. R. Soc. Trop. Med. Hyg. 81 (1987) 554-558.
14. Price, R. N., Nosten, F., Luxemburger, C., Kham, A., Brockman, A., Chongsuphajaisiddhi, T., White, N. J.: Artesunate versus artemether in combination with mefloquine for the treatment of multidrug-resistant falciparum malaria. Trans. R. Soc.Trop. Med. Hyg. 89 (1995) 523-527.
15. Brooks, D., Wang, P., Read, M., Watkins, W., Sims, P., Hyde, J.: Sequence variation in the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthetase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur. J. Biochem. 224 (1994) 397-405.
16. Warhurst, D. C.: Antimalarial drug discovery; development of inhibitors of dihydrofolate reductase active in drug resistance. Drug Discovery Today 3 (1998) 538-546.
17. Kiatfuengfoo, R., Suthiphongchai, T., Prapunwattana, P., Yuthavong, Y.: Mitochondria as the site of action of tetracycline on Plasmodium falciparum. Mol. Biochem. Parasitol. 34 (1989) 109-115.
18. Bradley, D. J., Warhurst, D. C.: Guidelines for the prevention of malaria in travellers from the United Kingdom. Commun. Dis. Rep. 10 (1997) 138-151.
19. Srivastava, I. K., Rottenberg, H., Vaidya, A. B.: Atovaquone, a broad spectrum antiparasitic drug, collapses mitochondrial membrane potential in a malaria parasite. J. Biol. Chem. 272 (1997) 3961-3966.
20. Looarcesuwan, S., Viravan, S., Webster, H. K., Kyle, D. F., Hutchinson, D. B., Canfield, C. J.: Clinical studies of atovaquone, alone or in combination with other antimalarial drugs, for the treatment of acute uncomplicated malaria in Thailand. Am. J. Trop. Med. Hyg. 54 (1996) 62-66.
21. Murphy, A. D., Lang-Unnasch, N.: Alternative oxidase inhibitors potentiate the activity of atovaquone against Plasmodium falciparum. Antimicrob. Agents Chemother. 43 (1999) 651-654.
22. Brueckner, RP., Coster, T., Wesche, DL., Schmuklarsky, M., Schuster, BG.: Prophylaxis of Plasmodium falciparum infection in a human challenge model with WR 238605, a new 8-aminoquinoline antimalarial. Antimicrob. Agents Chemother. 42 (1998) 1293-1294.